AI Article Synopsis
- Colorectal cancer remains a leading cancer type and a major cause of cancer-related deaths in men, despite advancements in therapies and lifestyle education.
- Recent focus has shifted toward identifying molecular markers, especially (epi)genetic alterations, to improve the classification and management of this disease by predicting treatment responses.
- While many genetic markers have been studied, they often yield inconclusive results and are rarely used in practice; epigenetic alterations are gaining attention due to their potential reversibility with treatment, warranting further exploration.
Article Abstract
Despite therapeutic innovations and increasing education on lifestyle to prevent colorectal cancer, it is still one of the most common cancer types, and for men the second cause of cancer-related death. Lately, much attention has been given to identify molecular markers involved in colorectal cancer prognosis and treatment with the aim to develop a more accurate classification system based on (epi)genetic alterations and, in addition, find markers that could potentially enhance management of colorectal cancer by predicting treatment response in advance. Although many genetic markers have been claimed to have prognostic or predictive influence, results are often inconclusive and, with some exception, they are not used in standard practice. Epigenetic alterations have received less attention although they are probably even more interesting as they can potentially be reversed through drug treatment. This review describes the current knowledge on the prognostic and predictive value of epigenetic markers in colorectal cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/14622416.9.12.1903 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!